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Original Article
Objectives: With recent advances in nanoparticle manufacturing and applications, potential exposure to nanoparticles in various set-
tings is becoming increasing likely. No investigation has yet been performed to assess whether respiratory tract exposure to cerium 
oxide (CeO2) nanoparticles is associated with alterations in protein signaling, inflammation, and apoptosis in rat lungs. 
Methods: Specific-pathogen-free male Sprague-Dawley rats were instilled with either vehicle (saline) or CeO2 nanoparticles at a dos-
age of 7.0 mg/kg and euthanized 1, 3, 14, 28, 56, or 90 days after exposure. Lung tissues were collected and evaluated for the expres-
sion of proteins associated with inflammation and cellular apoptosis. 
Results: No change in lung weight was detected over the course of the study; however, cerium accumulation in the lungs, gross histo-
logical changes, an increased Bax to Bcl-2 ratio, elevated cleaved caspase-3 protein levels, increased phosphorylation of p38 MAPK, 
and diminished phosphorylation of ERK-1/2-MAPK were detected after CeO2 instillation (p<0.05). 
Conclusions: Taken together, these data suggest that high-dose respiratory exposure to CeO2 nanoparticles is associated with lung 
inflammation, the activation of signaling protein kinases, and cellular apoptosis, which may be indicative of a long-term localized in-
flammatory response.
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INTRODUCTION
Cerium is a lanthanide metal that can undergo redox cycling 
depending on the partial pressure of oxygen in the surround-
ing environment [1]. The industrial production and utilization 
of cerium oxide (CeO2) nanoparticles is increasing rapidly in the 
polishing, energy, electronic, automobile, and biomedical in-
dustries [2]. Recently, CeO2 nanoparticles have been used as 
catalysts in combustion engines to reduce particulate emis-
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sions and increase fuel efficiency [3]. Other work has demon-
strated that CeO2 nanoparticles may exhibit antioxidant activity 
[4], which has led to the suggestion that these particles may be 
useful for the treatment of cardiovascular disease [5], neuronal 
injury [6], and the prevention of radiation-induced damage [7]. 
In addition to the beneficial applications of CeO2 nanoparti-
cles, some researchers have begun to examine whether these 
materials may also be toxic. In vitro studies using lung cancer 
cells (A549) [8] and bronchoalveolar epithelial cells (BEAS2B) [9] 
have suggested that cellular exposure to CeO2 nanoparticles 
may be associated with the increased production of reactive 
oxygen species and the induction of cellular apoptosis. Other 
work using intact rats has demonstrated that exposure to CeO2 
nanoparticles can cause lung inflammation and fibrosis [10-
12]. How exposure to CeO2 nanoparticles may induce lung in-
flammation and remodeling has not been fully elucidated. 
Mitogen-activated protein kinases (MAPKs), including the ex-
tracellular signal-regulated kinase (ERK)-1/2-MAPK, p38 MAPK, 
and c-Jun amino terminal kinase (JNK), are a family of serine/
threonine-specific kinases that transduce extracellular stimuli 
and are involved in the regulation of cell proliferation, gene ex-
pression, and apoptosis [13,14]. Previous work has suggested 
that several metals, including arsenic, zinc, and chromium, can 
induce the phosphorylation of MAPK proteins [15]. To the best 
of our knowledge, no studies have yet investigated whether ex-
posure to CeO2 nanoparticles can elicit similar activity. 
The primary goal of this study was to determine if exposure 
to CeO2 nanoparticles is associated with the activation of MAPK 
signaling and cellular apoptosis in the lungs of intact rats. Our 
data suggest that exposure to CeO2 nanoparticles is associated 
with cerium accumulation in the lungs, an increased Bax to Bcl-
2 ratio, elevated caspase-3 protein levels, increased phosphory-
lation of p38 MAPK, and diminished phosphorylation of ERK-
1/2-MAPK (p<0.05). Taken together, these data suggest that ex-
posure to CeO2 nanoparticles is associated with activation of 
MAPK signaling along with cellular apoptosis. 
METHODS
Particle Characterization 
CeO2 nanoparticles with an average hydrodynamic diameter 
of approximately 20 nm and average physical diameter of ap-
proximately 10 nm were obtained from Sigma-Aldrich (St. Lou-
is, MO, USA), corresponding to the specifications of nanoparti-
cles used in previous experiments [12]. Normal saline was used 
to suspend the nanoparticles prior to instillation. Diluted parti-
cle suspensions were filtered, sputter-coated, and examined 
with a Hitachi Model S-4800 Field Emission scanning electron 
microscope (Schaumburg, IL, USA) at 5 kV and 20 kV, or placed 
on a formvar-coated copper grid to dry and imaged with a 
JEOL 1220 transmission electron microscope (Tokyo, Japan), as 
previously described [16]. 
Animal Handling and Instillation of Cerium Oxide 
Nanoparticles
All procedures were performed in accordance with the Mar-
shall University Animal Care and Use Committee guidelines, us-
ing the criteria outlined by the Association for Assessment and 
Accreditation of Laboratory Animal Care (AAALAC). Five-week-
old (150 to 174 g) specific-pathogen-free male Sprague-Daw-
ley (Hla: SD-CVF) rats were purchased from Hilltop Lab Animals, 
Inc. (Scottdale, PA, USA). Rats were housed two per cage in an 
AAALAC-approved vivarium with a 12-hour light-dark cycle 
and maintained at 22±2˚C. Animals were allowed access to 
food and water ad libitum. All animals were allowed to acclima-
tize for two weeks before the study began. All animals were ex-
amined for precipitous weight loss, failure to thrive, or unex-
pected gait. Periodic weight measurements were taken through-
out the duration of the study.
After acclimatization, the animals were randomly divided 
into 12 groups (n=6 per group). After anesthetization, the ani-
mals were placed on an inclined restraint board and instilled 
with 0.3 mL of a saline suspension of CeO2 nanoparticles at a 
dosage of 7.0 mg/kg or 0.3 mL of saline, as described elsewhere 
[16]. This dose was selected based on previously published data 
by Ma et al.  [17] demonstrating a dose-dependent response in 
lung cells. 
Tissue Collection
Rats were anesthetized at 1, 3, 14, 28, 56, or 90 days post-ex-
posure, using a ketamine (40 mg/kg) and xylazine (10 mg/kg) 
cocktail (administered intraperitoneally), supplemented as 
necessary to ensure the loss of reflexive responses. After mid-
line laparotomy, the lungs were removed and placed in Krebs-
Ringer bicarbonate buffer, containing 118 mM NaCl, 4.7 mM 
KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 24.2 mM 
NaHCO3, and 10 mM α-D-glucose (pH 7.4), equilibrated with 5% 
CO2/95% O2, and maintained at 37˚C. Blood and other tissue 
materials were removed from the isolated lungs, weighed im-
mediately, and snap-frozen in liquid nitrogen.
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Determination of Cerium  Content in the Lungs
Cerium content in the lungs was estimated by induction cou-
pled plasma-mass spectrometry (ICP-MS) at Elemental Analysis, 
Inc. (Lexington, KY, USA) according to standard protocols as de-
scribed elsewhere [16]. The cerium concentration was estimated 
for the 1, 3, 14, 28, and 90-day post-exposure groups. Briefly, 
lung samples (n=4 for each group) were prepared using the En-
vironmental Protection Agency method 3050B for the analysis of 
total cerium by ICP-MS. Samples was weighed and digested with 
concentrated nitric acid, concentrated hydrochloric acid, and 
30% hydrogen peroxide. Samples were diluted and compared 
against a laboratory control sample using an Agilent 7500cx ICP-
MS machine (Agilent Technologies, Santa Clara, CA, USA). 
Histopathological Examination
Histopathological examination was performed on lungs from 
the day 1 saline control group, and in groups that had been ex-
posed to CeO2 for 1, 3, 14, and 28 days, using hematoxylin-eo-
sin (H&E) staining on formalin-fixed lung tissues. Using stan-
dard histopathological techniques lung tissues were embed-
ded in paraffin wax, sectioned at 5 μm, mounted on glass 
slides, and stained with H&E. In a blinded fashion, sections 
were examined by light microscopy by a board-certified pa-
thologist.
Immunoblotting Analysis 
Portions of individual lung tissues (100 to 150 mg) were ho-
mogenized in lysis buffer (T-PER, 8 mL/g of tissue; Pierce, Rock-
ford, IL, USA) containing phosphatase inhibitors (Sigma-Aldrich) 
and protease (Sigma-Aldrich). Tissue homogenates were soni-
cated for three cycles for 30 seconds at 150 W. The supernatant 
protein was collected by centrifuging the tissue homogenate at 
12 000×g for five minutes at 4˚C. The protein concentration of 
homogenates was determined via the 660-nm assay method 
(Fisher Scientific, Rockford, IL, USA). Equal concentrations of the 
protein samples were prepared from individual animals by add-
ing equal quantities of Laemmli 2X sample buffer (Sigma-Al-
drich) and adjusting the protein concentration with the T-PER 
lysis buffer.  Immunoblotting was performed on the prepared 
samples as described in Kakarla et al. [18] using the primary an-
tibodies against caspase-3 (1:1000 dilution in 5% bovine serum 
albumin [BSA] in TBST) (#9662), cleaved caspase-3 (1:500 dilu-
tion in 5% BSA in TBST) (#9661S), Bax (1:1000 dilution in 5% 
BSA in TBST) (#2772), Bcl2 (1:1000 dilution in 5% BSA in TBST) 
(#2870S), caspase-9 (1:1000 dilution in 5% BSA in TBST) (#9506), 
ERK-1/2 Thr 202/Tyr204 (1:1000 dilution in 5% BSA in TBST) 
(#9106S), phosphorylated ERK-1/2 (1:1000 dilution in 5% BSA 
in TBST) Thr 202/Tyr204 (#4377S), JNK (1:500 dilution in 5% BSA 
in TBST) (#9252), phosphorylated JNK Thr 183/Tyr185 (1:500 di-
lution in 5% BSA in TBST) (#9251S), p38 MAPK (1:1000 dilution 
in 5% BSA in TBST) (#9212), phosphorylated p38 MAPK Thr 180/
Tyr 182 (1:1000 dilution in 5% BSA in TBST) (#9216L), JAK-2 
(1:1000 dilution in 5% BSA in TBST) (#3229), phosphorylated 
JAK-2 Tyr 1007/100 (1:1000 dilution in 5% BSA in TBST) (#3776), 
STAT-3 (1:500 dilution in 5% BSA in TBST) (#9132), and phos-
phorylated STAT-3 Tyr 705 (1:500 dilution in 5% BSA in TBST) 
(#9131S) were purchased from Cell Signaling Technology (Bev-
erly, MA, USA).
Data Analysis
Data were analyzed using the SigmaPlot version 11.0 (Systat 
Software Inc., San Jose, CA, USA). Results are presented as 
mean±standard error of the mean. To determine overall com-
parisons one-way analysis of variance and two-way analysis of 
variance were performed, followed by a Student-Newman-Keuls 
post hoc test to determine differences between groups. A p-val-
ue <0.05 was considered statistically significant.
RESULTS
Nanoparticle Characterization
Similar to previous research [12,16] using CeO2 nanoparticles 
made to the same specifications, the analysis of nanoparticle 
size by scanning electron microscopy and transmission elec-
tron microscopy confirmed the presence of single and agglom-
erated CeO2 nanoparticles in the suspension. Field emission 
scanning electron microscopy showed submicron groups dis-
persion of CeO2 nanoparticles with an average size of 9.26±
0.58 nm. Determination of the diameter of the primary CeO2 
particles was 10.14±0.76 nm when evaluated by transmission 
electron microscopy.
Accumulation of Cerium in the Lung Over Time 
After Exposure
The concentration of cerium in the lungs was estimated using 
ICP-MS (Elemental Analysis). The concentration of cerium in the 
lungs decreased as post-exposure time increased. The concen-
tration of cerium in lung tissue at 14, 28, and 90 days post-expo-
sure was significantly lower than in tissue obtained one day af-
ter exposure to CeO2 nanoparticles, as shown in Figure 1. 
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ratio in exposed animals was 99% higher three days after ex-
posure (p<0.05) before declining thereafter. Compared to the 
day 1 saline control group, the Bax to Bcl-2 ratio was 37, 23, and 
14% lower at days 14, 28, and 56, respectively, in animals ex-
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Figure 1. Cerium concentration in the lungs appears to dimin-
ish over time. Lung tissues (approximately 1 g) were used for es-
timation of the cerium content in the lungs through induction 
couple plasma-mass spectrometry analysis. Con-1 represents 
the day 1 saline control group, while CeO2-1, 3, 14, 28, and 90 
represent the groups exposed to cerium oxide (CeO2) nanopar-
ticles for 1, 3, 14, 28, and 90 days respectively. One-way analysis 
of variance was performed for overall comparisons, while the 
Student-Newman-Keuls post hoc test was used to determine 
differences between groups. *p<0.05 between the day 1 saline 
control group, †p<0.05 between the CeO2 day 1 group. 
A B
C D
Figure 2. Gross alterations in the lungs with exposure to ce-
rium oxide (CeO2) nanoparticles include increased weight, 
black discoloration of the lungs, and the appearance of white 
nodules on the surface. The white nodules appeared to in-
crease with longer exposure, and the white nodules appeared 
to coalesce to form bigger nodules at day 90. (A) Saline control 
lungs day 1, (B) CeO2 exposed lungs (7.0 mg/kg) day 28, (C) 
CeO2 exposed lungs (7.0 mg/kg) day 56, and (D) CeO2 exposed 
lungs (7.0 mg/kg) day 90.
Exposure to Cerium Oxide Nanoparticles Alters 
the Gross Histological Appearance of the Lung
Alterations in the appearance of the lungs following exposure 
included the presence of areas of black discoloration and white 
pustular nodules on the surface of the lungs, which appeared 
to increase over time (Figure 2). Histological alterations includ-
ed an increased number of alveolar macrophages, an increased 
number of polymorphonuclear cells, and an apparent accumu-
lation of particulate material in the alveolar spaces (Figure 3).
Cerium Oxide Nanoparticles Increase Apoptotic 
Protein Signaling in the Lung 
Compared to the day 1 saline control group, the Bax to Bcl-2 
A B C D E
Figure 3. Alterations in the histological appearance of lungs associated with the instillation of CeO2 nanoparticles include an in-
creased number of alveolar macrophages, an increase in the number of polymorphonuclear white blood cells (short arrow), and 
the increased accumulation of particulate matter (long arrow) in the air spaces (400×). (A) Saline control-1 H&E lung 400X, (B) 
CeO2-1 H&E lung 400X, (C) CeO2-3 H&E lung 400X, (D) CeO2-14 H&E lung 400X, and (E) CeO2-28 H&E lung 400X. CeO2, cerium ox-
ide; H&E, hematoxylin and eosin; CeO2-n, lung tissues from the groups that had been exposed to CeO2 nanoparticles for n days.
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posed to CeO2 nanoparticles (p<0.05) (Figure 4).
In order to extend these findings, we next examined the reg-
ulation of the initiator (caspase-9) and the executor caspases 
(caspase-3) [18]. Compared to the day 1 saline control group, 
the total caspase-9 protein levels were reduced by 28, 6, 23, 21, 
and 32% in the 1, 3, 14, 56, and 90-day post-exposure groups 
(p<0.05). Compared to the day 1 saline control group, the ex-
pression of the 38-kDa and 40-kDa cleaved fragments of cas-
pase-9 was increased by 20% in the 3, 14, and 28-day post-ex-
posure groups (p<0.05) (Figure 4).
Caspase-3 protein expression levels increased by 56% 
(p<0.05) and 20% (p<0.05) in the 3 and 14-day exposure 
groups, when compared to the day 1 saline control group. 
Compared to the day 1 saline control group, the protein expres-
sion of the cleaved fragments of caspase-3 (17 kDa and 19 kDa) 
were increased by 10, 88, 66, 119, 77, and 39% in the 1, 3, 14, 
28, 56, and 90-day post-exposure groups (p<0.05) (Figure 4). 
Cerium Oxide Nanoparticle Exposure Is Associ-
ated With Activation of Mitogen-activated Pro-
tein Kinase Signaling
Compared to the day 1 saline control group, the ratio of phos-
phorylated p38 MAPK (Thr180/Tyr182) to total p38 MAPK was 
reduced by 22 and 14% in the day 1 and day 3 post-exposure 
groups (p<0.05). However, this ratio was elevated by 52, 15, and 
10% in the 14, 28, and 56-day post-exposure groups, before it 
declined by 19% in the 90-day post-exposure group (p<0.05) 
(Figure 5). 
The ratio of phosphorylated ERK-1/2 (Thr202/Tyr204) to total 
ERK-1/2 was reduced by 43, 57, 56, 62, 53, and 41% in the 1, 3, 
14, 28, 56, and 90-day post-exposure groups compared to the 
day 1 saline control group (p<0.05) (Figure 5). In contrast, the 
Figure 4. Cerium oxide (CeO2) nanoparticles increase pro-
apoptotic protein signaling in the lungs. Protein bands of the 
Bax, Bcl-2 (A), caspase-9, cleaved caspase-9 (B), and cas-
pase-3, cleaved caspase-3 (C) proteins, along with the corre-
sponding glyceraldehyde 3-phosphate dehydrogenase (GAP-
DH) levels, are represented in the figure. Bands correspond-
ing to the X-axis labels are shown in the immunoblotting im-
ages. The protein levels were adjusted depending on the 
GAPDH levels and compared with the day 1 control group. 
One-way analysis of variance was performed for overall com-
parisons, while the Student-Newman-Keuls post hoc test was 
used to determine differences between groups. *p<0.05 be-
tween the day 1 saline control group.
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The primary finding of the current study is that pulmonary ex-
posure to CeO2 nanoparticles is associated with histological 
evidence of lung inflammation, the activation of MAPK signal-
ing, the phosphorylation of STAT-3, increased caspase-3 cleav-
age, and inflammation. 
The data from the current study show that the instillation of 
CeO2 nanoparticles leads to the deposition of cerium in the 
lungs, as shown by ICP-MS (Figure 1). We also observed that 
exposure to CeO2 nanoparticles was associated with the devel-
opment of white nodular structures on the lung surface (Table 
1, Figures 2 and 3). Recent work has shown that nanoparticles 
such as carbon nanotubes, titanium dioxide nanoparticles, and 
polyacrylate nanoparticles can induce granulomas on the lung 
surface [21-23]. It is possible that the white nodules we ob-
served in the present study may be the byproduct of an ongo-
ing inflammatory reaction, which could result in either the 
clearance of the nanoparticles or their further development 
into granulomas on the surface of the lungs [22,24]. The afore-
mentioned possibility is consistent with our histopathological 
analysis, in which we observed an increase in the number of al-
Figure 5. Activation of mitogen-activated protein kinase 
(MAPK) protein signaling was observed with the instillation of 
cerium oxide (CeO2) nanoparticles. Protein bands of the p38 
MAPK, phosphorylated p38 MAPK (A), ERK-1/2-MAPK, phos-
phorylated ERK-1/2-MAPK (B), and JNK, phosphorylated JNK 
(C) proteins, along with the corresponding glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) levels are represented 
in the figure bands corresponding to the X-axis labels and are 
shown in the immunoblotting images. Protein levels were ad-
justed according to the GAPDH levels and compared with the 
day 1 control group. One-way analysis of variance was per-
formed for overall comparisons, while the Student-Newman-
Keuls post hoc test was used to determine differences be-
tween groups. *p<0.05 between the day 1 saline control 
group. 
1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
Con-1 CeO2-1 CeO2-3 CeO2-14 CeO2-28 CeO2-56 CeO2-90
Ph
os
ph
o 
to
 to
ta
l p
38
 M
AP
K
(T
hr
18
0/
Ty
r1
82
) r
at
io
 (A
U)
* *
*
* *
*
Phospho (Thr180/Tyr182) p38 MAPK
p38 MAPK
GAPDH
A
1.2
1.0
0.8
0.6
0.4
0.2
0.0
Con-1 CeO2-1 CeO2-3 CeO2-14 CeO2-28 CeO2-56 CeO2-90
Ph
os
ph
o 
to
 to
ta
l E
RK
-1
/2
 
(T
hr
20
2/
Ty
r2
04
) r
at
io
 (A
U)
*
* * *
*
*
Phospho (Thr202/Tyr204) ERK-1/2
ERK-1/2
GAPDH
B
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
Con-1 CeO2-1 CeO2-3 CeO2-14 CeO2-28 CeO2-56 CeO2-90
Ph
os
ph
o 
to
 to
ta
l J
N
K1
-2
 
(T
hr
18
3/
Ty
r1
85
) r
at
io
 (A
U)
*
Phospho (Thr183/Tyr185) JNK
JNK
GAPDH
C
ratio of phosphorylated (Thr183/Tyr185) JNK to total JNK was 
unaltered following nanoparticle exposure (Figure 5). 
 
Cerium Oxide Nanoparticles Activate Inflamma-
tory Protein Signaling Through p38 MAPK Medi-
ated STAT-3 Activation 
It is known that JAK-2 and STAT-3 play a crucial role in inflam-
mation [19]. When compared to the day 1 saline control group, 
the ratio of phosphorylated (Tyr705) to total STAT-3 protein was 
111, 193, and 106% higher at 3, 14, and 28 days after exposure 
(p<0.05) (Figure 6). The ratio of phosphorylated (Tyr1007/1008) 
JAK-2 to total JAK-2 was 25 and 103% higher in the 1 and 90-
day post-exposure groups compared to the control animals (p<  
0.05) (Figure 6).
DISCUSSION
Previous In vitro and in vivo studies have suggested that ex-
posure to CeO2 nanoparticles can elicit toxic effects, although 
the underlying mechanism is not well understood [3,8,12,20]. 
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veolar macrophages and polymorphonuclear white blood cells 
in the lungs of animals that had been exposed to CeO2 nanopar-
ticles. It is thought that the toxic effects of most nanoparticles 
(silver, silica, titanium dioxide, zinc oxide, and carbonaceous 
nanoparticles) are characterized by increased oxidative stress 
[25-29]. Whether these increases in oxidative stress are due to in-
creased reactive oxygen species (ROS) generation or decreased 
ROS scavenging is currently unclear, although many metallic ox-
ide nanoparticles have been shown to increase ROS production 
[30,31]. 
Increased ROS levels may also induce apoptotic signaling. We 
observed an increase in the pro-apoptotic Bax to Bcl-2 ratio at 
one and three days after the exposure to CeO2 nanoparticles, 
with a subsequent decline. Since the Bax to Bcl-2 ratio is an in-
dicator of whether a cell is likely to undergo apoptosis [18,32], 
we next examined the possibility that CeO2 nanoparticle expo-
sure may be associated with the activation of caspase-3. Con-
sistent with the Bax/Bcl-2 data, we found that caspase-3 cleav-
age (activation) was elevated at 3, 14, 28, and 56 days post-ex-
posure. Why caspase-3 cleavage was present in the absence of 
an elevated Bax/Bcl-2 ratio is currently unclear. Other signaling 
pathways (extrinsic or intrinsic pathways) that activate the 
apoptotic pathway may be in play and explain the possible ac-
tivation of effector caspase-3 in the absence of an elevated 
Bax/Bcl-2 ratio. It is thought that mild lung injury may elicit the 
repair of the damaged tissue, whereas excessive apoptosis-in-
duced cell death may lead to the development of lung remod-
eling and fibrosis [33]. Bearing this in mind, the activation of 
caspase-3 we identified in the current study may help to ex-
plain previous findings that increased lung fibrosis follows ex-
posure to CeO2 nanoparticles [12].
MAPKs are stress-responsive proteins that can be activated 
by growth factors, chemicals, ultraviolet radiation, heat, syn-
thesis inhibitors, metals, or foreign organisms [34]. MAPK path-
ways have been shown to play important roles in oxidative 
stress and inflammation induced by nanoparticles and metals 
[15,31]. The three primary members of the MAPK signaling 
modules are the p38, JNK, and ERK-1/2 MAPKs. MAPK proteins 
are thought to phosphorylate (activate) transcription factors 
that are involved in regulating both cell survival and cell death. 
In the present study, exposure to CeO2 nanoparticles was asso-
ciated with increased phosphorylation of p38 MAPK at 14, 28, 
and 56 days after exposure. Conversely, we found that ERK-
1/2-MAPK activity appeared to be impaired by CeO2 nanopar-
ticles (Figure 5). Since ERK-1/2-MAPK is thought to play an im-
portant role in cell survival and p38 MAPK may play an impor-
tant role in apoptosis [34], these differences in MAPK signaling 
may help to explain the sustained caspase-3 cleavage after 
the pro-apoptotic Bax to Bcl-2 ratio returned to normal. 
It is well known that nanoparticle exposure is often associ-
ated with increased levels of cytokines, interleukins, and other 
mediators of inflammation. The Janus kinase/signal transduc-
ers and activators of transcription (JAK/STAT) pathway is a par-
ticularly important pathway in mediating inflammation [19]. 
Interestingly, JAK-2 did not appear to play an important role in 
the toxicological response, as its phosphorylation (Tyr1007/ 
1008) was elevated only at day 1 and day 90 (Figure 6). Con-
versely, the phosphorylation of STAT-3 (Tyr705) seemed to 
Table 1. Cerium oxide (CeO2) nanoparticle exposure increases the ratio of lung weight to body weight 
Exposure (d)
Body weight (g) Lung weight (g)
Saline control CeO2 (7.0 mg/kg) Saline control CeO2 (7.0 mg/kg)
  1 319.67±15.92 319.67±15.20 1.74±0.28 1.88±0.08
  3 310.33±28.10 331.67±24.00 1.54±0.27 2.19±0.15
14 345.67±27.11 332.33±21.07 1.90±0.31 2.12±0.23
28 411.33±29.21,3 403.67±28.941,3 1.82±0.09 2.43±0.30
56 451.67±26.211-3 451.00±34.61-4 1.56±0.24 2.84±0.58
90 523.33±60.871-5 519.33±44.841-5 1.62±0.11 2.75±0.51
Lung tissues were collected from groups of animals that were intratracheally instilled with either normal saline or CeO2 nanoparticles at a dosage of 7.0 mg/kg, 
at 1, 3, 14, 28, 56, and 90 days after exposure. The lung tissues were cleaned to remove blood and tissue debris with Krebs’s lactate solution and weighed im-
mediately (n=6/group). Two-way analysis of variance was performed for overall comparisons, while the Student-Newman-Keuls post hoc test was used to de-
termine differences between groups; p<0.05 were considered to indicate statistical significance.
1Significantly different from the one-day exposure group for a given condition.
2Significantly different from the three-day exposure group for a given condition.
3Significantly different from the 14-day exposure group for a given condition.
4Significantly different from the 28-day exposure group.
5Significantly different from the 56-day exposure group.
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Figure 6. Activation of STAT-3 after exposure to cerium oxide (CeO2) nanoparticles follows the activation of p38 MAPK. The protein 
bands of the STAT-3, phosphorylated STAT-3 (A) and  JAK-2, phosphorylated JAK-2 (B) proteins, along with the corresponding glyc-
eraldehyde 3-phosphate and dehydrogenase (GAPDH) values, are represented in the figure. The bands corresponding to the X-ax-
is labels are shown in the immunoblotting images. The protein levels were adjusted according to the GAPDH levels and compared 
with the day 1 control. One-way analysis of variance was performed for overall comparisons, while the Student-Newman-Keuls 
post hoc test was used to determine differences between groups. *p<0.05 between the day 1 saline control group.
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parallel p38 MAPK activation (Figure 6). A previous study has 
demonstrated that p38 MAPK can act as an upstream activa-
tor of STAT-3, which, in turn, can induce apoptosis when acti-
vated [35]. Other research has shown that the p38 MAPK and 
STAT-3 signaling pathways can work in concert or separately 
to exert apoptotic effects on the cells [36]. These data, consid-
ered in light of our findings regarding the increased Bax to Bcl-
2 ratio, are consistent with the possibility that apoptosis medi-
ated by CeO2 nanoparticles is mediated through the activation 
of the p38 MAPK and STAT-3 signaling pathways.    
In summary, our data suggest that lung exposure to CeO2 
nanoparticles is associated with the increased accumulation 
of cerium in the lungs and gross pathological and histological 
alterations to the lungs. It also appears that CeO2 nanoparti-
cles can induce inflammation and apoptotic protein signaling 
in the lungs. Overall, the data from the current study indicate 
that CeO2 nanoparticle-induced inflammation and apoptosis 
may be mediated through the activation of the stress-respon-
sive MAPK protein signaling pathway, the phosphorylation of 
STAT-3, and the activation of the intrinsic apoptosis pathway 
(Figure 6). Given these findings, additional research to evalu-
ate the role of subcellular organelles in inducing apoptosis in 
these conditions is likely warranted.
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